<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Calibri",sans-serif;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#002060;}
span.EmailStyle22
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#002060;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt;color:red">The following email is being forwarded at the request of Dr. Randy Smith, Senior Associate Dean<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:#002060"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:#002060"><o:p> </o:p></span></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal">Attached is information regarding our upcoming program, <i>Advances in Cancer Immunotherapy.
</i>This is the sixth year we’ve hosted this program and it has received incredibly positive feedback from nurses, physicians and pharmacists who have attended. The program covers the basics of cancer immunotherapy; how to and when to use it in treating melanoma,
lung cancer, GU cancers, hematologic malignancies and head and neck cancer; practical barriers in implementation; and most importantly, how to manage patients and the side effects/adverse events of the treatment.<o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal"><span style="color:black">Sanjiv S. Agarwala, MD of St. Luke’s Cancer Center and Temple University, Robert L. Ferris, MD, PhD of UPMC Hillman Cancer Center, and Amy Schippers, PA-C of St. Luke’s University & Health Network, St. Luke’s Cancer
Center are organizers of the program and they’ll be available to answer questions throughout the session. New this year, an interactive format and attendance is
<b>FREE</b> for all those who work in clinical settings. Are you able to pass this program information to your students and colleagues who would benefit from attending this program?
</span><o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal">Thanks in advance for any help you can provide.<o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal">Best,<o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
<p class="MsoNormal"><b><span style="color:black">Kathryn Behling</span></b><span style="font-size:10.0pt;color:black"><br>
</span><span style="color:black">Project Manager</span><span style="font-size:10.0pt;color:black"><br>
Society for Immunotherapy of Cancer (SITC)<br>
555 E. Wells Street, Ste. 1100</span><o:p></o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;color:black">Milwaukee, WI 53202</span><span style="color:black"><br>
</span><span style="font-size:10.0pt">+1 414 271 8237 | <a href="mailto:kbehling@sitcancer.org">
kbehling@sitcancer.org</a> | </span><a href="https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.sitcancer.org%2F&data=02%7C01%7Crxdean%40pitt.edu%7C237ddbffa558487efe5208d63a8784fc%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C636760751185476053&sdata=VHaOPXrf%2BtT2EKutmqs%2FwDXLLW2rPx%2FUQB1ICbhCwLs%3D&reserved=0"><span style="font-size:10.0pt">www.sitcancer.org</span></a><span style="font-size:10.0pt;color:#2B2E73">
| Twitter: </span><a href="https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2Fsitcancer&data=02%7C01%7Crxdean%40pitt.edu%7C237ddbffa558487efe5208d63a8784fc%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C636760751185486057&sdata=KPUPmOYjFaZrDt%2F6nh%2BuHs%2FCeuRLFIf%2Bhsbpj70uHFY%3D&reserved=0"><span style="font-size:10.0pt">@sitcancer</span></a><span style="color:#1F497D">
</span><span style="font-size:10.0pt;color:#2B2E73">| Facebook: </span><a href="https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.facebook.com%2Fpages%2FSociety-for-Immunotherapy-of-Cancer-SITC%2F220828988248393&data=02%7C01%7Crxdean%40pitt.edu%7C237ddbffa558487efe5208d63a8784fc%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C636760751185496067&sdata=LwSR6rrOpoKZLlvXYBE28HIntvCYI6%2Bp%2BNxZ4pAjhu4%3D&reserved=0"><span style="font-size:10.0pt">@sitcancer</span></a><o:p></o:p></p>
<p class="MsoNormal" style="text-autospace:none"><u><br>
</u><b><span style="color:black">Attend SITC 2018 on Nov. 7-11</span></b><o:p></o:p></p>
<p class="MsoNormal" style="text-autospace:none"><a href="https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sitcancer.org%2F2018%2Fabstracts%2Ftitles&data=02%7C01%7Crxdean%40pitt.edu%7C237ddbffa558487efe5208d63a8784fc%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C636760751185496067&sdata=S0jkwq7DtLn%2F7cw2b9QMRi%2B1HbRyF3VDZ7NMzNKKWww%3D&reserved=0">Nearly
800 abstract titles of research</a><span style="color:black"> set for presentation at the 33<sup>rd</sup> Annual Meeting & Pre-Conference Programs are now online.
</span><a href="https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sitcancer.org%2F2018%2Fattendee-resources%2Fregistration&data=02%7C01%7Crxdean%40pitt.edu%7C237ddbffa558487efe5208d63a8784fc%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C636760751185506072&sdata=V%2FEOS4i4vsOr%2BKvB7KRZC8khrdyv2DJVYvTXQYrzAoc%3D&reserved=0">Register
now to attend SITC 2018</a><span style="color:black"> this November in Washington, D.C., at the Walter E. Washington Convention Center.</span><o:p></o:p></p>
<p class="MsoNormal" style="text-autospace:none"> <o:p></o:p></p>
<p class="MsoNormal"> <o:p></o:p></p>
</div>
</body>
</html>